• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Egg Allergy Market

    ID: MRFR/Pharma/3312-CR
    85 Pages
    Rahul Gotadki
    June 2024

    Egg Allergy Market Research Report Information by Age Group (Children and Adults), Diagnosis & Treatment (Diagnosis [Skin Test, Blood Test, Food Challenge and others] and Treatment [Medication and Oral Immunotherapy]), End User (Hospitals and Clinics, Diagnostic Centers, Research Institutes and others) - Forecast till 2030

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Egg Allergy Market by Share, Size, Growth and Overview – 2030 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    Egg Allergy Market Summary

    The Global Egg Allergy Market is projected to grow from 1.48 USD Billion in 2024 to 2.81 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Global Egg Allergy Key Trends and Highlights

    • The market is expected to expand at a compound annual growth rate (CAGR) of 6.0 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 2.81 USD Billion, indicating a substantial increase from the base year.
    • In 2024, the market is valued at 1.48 USD Billion, laying a strong foundation for future growth.
    • Growing adoption of allergen-free food products due to rising awareness of food allergies is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.48 (USD Billion)
    2035 Market Size 2.81 (USD Billion)
    CAGR (2025-2035) 6.0%

    Major Players

    Genentech, Inc. (the US), Sanofi SA (France), ImmuneTech (US), Quest Diagnostics (US), HYCOR Biomedical (US), Alletess Medical Laboratory (US), Kaleo, Inc. (the US), Imutest Ltd (UK), Creative Diagnostics (US), Impax Laboratories (US), Mylan NV (US)

    Egg Allergy Market Trends

      • Major drivers of the market

    The egg allergy market size is evolving at a faster pace, and in the upcoming times, it will grow immensely. The number of cases of egg allergies is increasing day by day, both in adults as well as infants. Most number of cases over the years has happened to children more than egg allergy in adults. Symptoms of egg allergy in children outgrow way before it results in egg allergy symptoms in adults. The food allergy prevalence has increased to a greater extent which acts as a driving force for the growth of the global egg allergy market.

    Several technological advancements in egg allergy medication and treatment resulted in propelling the egg allergy market size. 

    The technological advancements in egg allergy treatment and diagnosis methods include skin prick test, food challenge, blood test, oral immunotherapy, and many more. These advanced methods of treatment increase the skin allergy test market size and help to propagate the growth of the egg allergy market to the optimum level in the forecast period.

      • Significant growth opportunities for the market

    The egg allergy market is increasing to greater heights in a short time span, and the market will continue to grow in the future due to an extreme increase in egg allergy cases. The skin allergy test market size is rising exponentially with the advanced technological methods of diagnosis and treatment. These advancements are not just limited to egg allergy treatment but also include advancements in the identification process and screening. Various food scanners, apps, portable devices, and wearable are helpful in determining different food ingredients related to egg allergy.

    These devices are major opportunities for increasing the egg allergy industry size in the upcoming years.

      • Market restraints

    The global egg allergy market is definitely growing at a faster rate, but the market growth can be hindered due to a lack of awareness among patients. The developing countries tend to avoid allergies, and the reason behind it lacks awareness. Many patients overlook the allergies and do not take any egg allergy treatment on time. The egg allergy cases in these countries are comparatively low, and the poor healthcare sector is also responsible for the same. Another prime restraint for the egg allergy industry is the hefty cost involved in the diagnosis and treatment process.

    Many tests are also not covered by any insurance policies. Such constraints restrict the growth of the egg allergy market size.

      • Market Growth Challenges

    The egg allergy market is immensely dependent on the number of cases of egg allergy patients. Many patients overlook and avoid egg allergy medication in time which leads to declining market growth. Various tests like radioallergosorbent test (RAST) and enzyme-linked immunosorbent assay (ELISA or EIA) has their own limitations, which sometimes show false results and diagnosis failure due to cross-contamination. These testing procedures also require proficient egg allergy industry therapeutics who can handle the tests properly, which hinders the market growth of the egg allergy market size.

    Value Chain Analysis

    The revenue of the egg allergy industry is continuously escalating over the years and will continue to grow in the forecast years. Various egg research and consultancy sectors are focusing on the prevention and cure of the disease. The continuous effort for producing better egg allergy medication has resulted in the increasing the market value of the egg allergy market. The expansion of skin allergy test market size will reach greater levels in the upcoming years.

    The prevalence of egg allergy among children appears to be on the rise, necessitating increased awareness and management strategies to address this growing public health concern.

    Centers for Disease Control and Prevention (CDC)

    Egg Allergy Market Drivers

    Rising Prevalence of Egg Allergy

    The increasing incidence of egg allergy, particularly among children, is a primary driver of the Global Global Egg Allergy Market Industry. Studies indicate that egg allergy affects approximately 1.5 to 2.5 percent of children globally, with many outgrowing it by adolescence. However, the persistent cases contribute to a growing demand for allergen-free products. As awareness of food allergies rises, parents and caregivers are more vigilant, leading to increased consumption of egg-free alternatives. This trend is expected to propel the market, with projections estimating the market value to reach 1.48 USD Billion in 2024.

    Market Segment Insights

    Egg Allergy Age Group Insights

    The egg allergy industry size segmentation on the basis of age group includes children and adults. The egg allergy symptoms in adults are very less compared to children, so the children have the largest share in the egg allergy industry. 

    Egg Allergy Treatment Insights

    The treatment segment consists of sub-segments that include egg allergy medication and oral immunotherapy process, whereas the diagnosis segment consists of tests like blood tests, skin tests, and others.

    Egg Allergy end-user Insights

    Egg allergy market segmentation on the basis of end-user comprises hospitals and clinics, egg research and consultancy, and diagnostics centers. 

    Get more detailed insights about Egg Allergy Market by Share, Size, Growth and Overview – 2030

    Regional Insights

    Key Companies in the Egg Allergy Market market include

    Industry Developments

    Future Outlook

    Egg Allergy Market Future Outlook

    The Global Egg Allergy Market is projected to grow at a 6.0% CAGR from 2024 to 2035, driven by rising awareness, innovative treatments, and increasing prevalence of allergies.

    New opportunities lie in:

    • Develop personalized dietary solutions for egg allergy patients.
    • Invest in research for novel immunotherapy treatments.
    • Expand product lines to include egg-free alternatives in mainstream markets.

    By 2035, the market is expected to demonstrate robust growth, reflecting heightened consumer demand and innovative solutions.

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size USD 2.01643 Billion by 2030
    CAGR 6.90% (2022-2030)
    Base Year   2021
    Forecast Period   2022-2030
    Historical Data   2020
    Forecast Units   Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Types, end user, Region
    Geographies Covered America, Europe, Asia Pacific, Middle East and Africa
    Key Vendors Genentech Inc. (the US), Sanofi SA (France), ImmuneTech (US), Quest Diagnostics (US), HYCOR Biomedical (US), Alletess Medical Laboratory (US), Kaleo Inc. (the US), Imutest Ltd (UK), Creative Diagnostics (US), Impax Laboratories (US), Mylan NV (US)

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    At what CAGR is the global egg allergy market projected to grow in the forecast period (2024-2032)?

    Egg allergy market projected to grow at approximately 6.90% CAGR during the assessment period (2022-2030).

    How much is the global egg allergy market worth in the future?

    The valuation of the global egg allergy market is estimated to increase to USD 2.016 Billion by the end of 2030

    What are the major tailwinds pushing the growth of the global egg allergy market?

    Increasing prevalence, improved allergy diagnosis, and rising healthcare expenses are major tailwinds pushing the growth of the global egg allergy market.

    Which region holds the largest share in the global egg allergy market?

    North America holds the largest share in the global egg allergy market, followed by Europe and the Asia Pacific, respectively.

    Who are the top players in the global egg allergy market?

    Genetech, Inc. (US), Mylan N.V. (US), Sanofi (France), Alletess Medical Laboratory (US), Creative Diagnostics (US), HYCOR Biomedical (US), Impax Laboratories, Inc. (US), Kaleo, Inc. (US), Kaleo, Inc. (US), Impax Laboratories (US), Quest Diagnostics (US), ImmuneTech (US), and Imutest Ltd. (UK), are some of the top players operating in the global egg allergy market.

    1. 'TABLE OF CONTENT    
    2. Chapter 1.    Report
    3. Prologue    
    4. Chapter 2.    Market Introduction  
      1.     Definition    
    5.  Scope of the Study    
      1.     Research
    6. Objective    
      1.     Assumptions  
        1.     Limitations    
    7. Chapter
    8.     Research Methodology
      1.     Introduction
      2.     Primary Research    
    9.  Secondary research    
      1.     Market Size
    10. Estimation
    11. Chapter 4.    Market Dynamics
    12.  Drivers    
      1.     Restrains
    13.  Opportunities    
      1.     Challenges
      2.     Macroeconomic Indicators
      3.     Technology
    14. Trends & Assessment            
    15. Chapter 5.    Market Factor Analysis
      1.     Porter’s
    16. Five Forces Analysis
      1.     Bargaining Power of Suppliers  
        1.     Bargaining Power of Buyers
    17.  Threat of New Entrants    
      1.     Threat
    18. of Substitutes    
      1.     Intensity of Rivalry  
      2.     Value Chain Analysis
      3.     Investment
    19. Feasibility Analysis    
      1.     Pricing Analysis
    20. Chapter 6.    Global Encephalomyelitis Market, by Type
    21.      6.1    Introduction
    22.  Acute Disseminated Encephalomyelitis
    23. Market Estimates & Forecast,
      1.     Encephalomyelitis Disseminata
    24. Market
    25. Estimates & Forecast, 2020 – 2027
      1.     Deprivation
    26. & Occlusion Encephalomyelitis
    27. Market Estimates & Forecast, 2020 –
      1.     AntiMOG Associated Encephalomyelitis
    28. Market
    29. Estimates & Forecast, 2020 – 2027
      1.     Equine Encephalomyelitis
    30. Market Estimates & Forecast, 2020 – 2027
      1.     AIDS
    31. Related Encephalomyelitis
    32. Market Estimates & Forecast, 2020 – 2027
    33.         6.8    Others
    34. Chapter
    35.     Global Encephalomyelitis Market, by Treatment
    36.      7.1    Introduction
    37.  Drug Treatment
    38. Market Estimates & Forecast, 2020 – 2027
      1.     Antiviral Medications
        1.     Antibiotics
        2.     Steroids
        3.     Sedatives
    39.  NSAIDs
      1.     Mood Stabilizers
    40.  Others
      1.     Plasmapheresis
    41. Market Estimates &
    42. Forecast, 2020 – 2027
      1.     Surgery
    43. Market Estimates
    44. & Forecast, 2020 – 2027
      1.     Others
    45. Chapter
    46.     Global Encephalomyelitis Market, by End User
    47.  Introduction
      1.     Hospitals
    48. Market Estimates &
    49. Forecast, 2020 – 2027
      1.     Clinics
    50. Market Estimates
    51. & Forecast, 2020 – 2027
      1.     Others
    52. Chapter
    53.     Global Encephalomyelitis Market, by Region
    54.  Introduction
      1.     America
        1.     North
    55. America
      1.     U.S.
        1.     Canada
        2.     South America
      2.     Europe
    56.  Western Europe
      1.     Germany
    57.  France
      1.     Italy
        1.     Spain
        2.     Eastern Europe
      2.     Asia Pacific
        1.     Japan
        2.     China
    58.  India
      1.     Australia
        1.     Republic
    59. of Korea
      1.     Rest of Asia Pacific
    60.  The Middle East & Africa
      1.     United Arab Emirates
        1.      Saudi Arabia
        2.     Oman
    61.  Kuwait
      1.     Qatar
        1.     Rest
    62. of the Middle East & Africa
    63. Chapter 10    Company Landscape  
      1.     Introduction    
    64.  Market Share Analysis    
      1.     Key Development
    65. & Strategies    
      1.     Key Developments  
    66. Chapter 11    Company Profiles    
      1.     Bristol-Myers Squibb Company     
    67.  Company Overview    
      1.     Product
    68. Overview    
      1.     Financials  
        1.     SWOT Analysis    
    69.  Sanofi     
      1.     Company Overview  
        1.     Product Overview    
    70.  Financial Overview    
      1.     Key Developments  
        1.     SWOT Analysis    
    71.  GlaxoSmithKline Plc.    
      1.     Company
    72. Overview    
      1.     Product Overview  
        1.     Financial Overview
    73.  Key Development    
      1.     SWOT Analysis  
      2.     Amgen, Inc
        1.     Company
    74. Overview    
      1.     Product/Business Segment
    75. Overview    
      1.     Financial Overview  
        1.     Key Development    
    76.  SWOT Analysis    
      1.     Bayer AG
    77.  Company Overview    
      1.     Product
    78. Overview    
      1.     Financial overview  
        1.     Key Developments    
    79.  Novartis AG     
      1.     Company Overview  
        1.     Product Overview    
    80.  Financial Overview    
      1.     Key Developments  
      2.     F. Hoffmann-La Roche Ltd
    81.  Overview    
      1.     Product Overview  
        1.     Financials    
    82.  Key Developments    
      1.     SWOT Analysis  
    83.     11.8    Others
    84. Chapter 12  
    85.  MRFR Conclusion    
      1.     Key Findings  
        1.     From CEO’s View Point    
        2.     Unmet Needs of the Market    
    86.  Key Companies to Watch    
      1.     Prediction
    87. of Pharmaceutical Industry
    88. Chapter 13    Appendix
    89. DATA
    90. Synopsis, 2020 – 2027
    91. Encephalomyelitis Market Estimates and Forecast, 2020 – 2027, (USD Million)
    92. Region, 2020 – 2027, (USD Million)
    93.  Global Encephalomyelitis Market by Types, 2020 – 2027, (USD Million)
    94. Treatment, 2020 – 2027, (USD Million)
    95.  Global Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    96. by Types, 2020 – 2027, (USD Million)
    97.  North America Encephalomyelitis Market by Treatment, 2020 – 2027, (USD
    98. Million)
    99. Market by End Users, 2020 – 2027, (USD Million)
    100.  US Market by Types, 2020 – 2027, (USD Million)
    101.  US Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    102. , (USD Million)
    103. – 2027, (USD Million)
    104. Market by Treatment, 2020 – 2027, (USD Million)
    105.  Canada Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    106. Million)
    107. by Treatment, 2020 – 2027, (USD Million)
    108. America Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    109. – 2027, (USD Million)
    110. Market by End Users, 2020 – 2027, (USD Million)
    111.  Western Europe Market by Types, 2020 – 2027, (USD Million)
    112.     Western Europe Encephalomyelitis Market by Treatment, 2020
    113. – 2027, (USD Million)
    114. Market by End Users, 2020 – 2027, (USD Million)
    115.  Eastern Europe Market by Types, 2020 – 2027, (USD Million)
    116.     Eastern Europe Encephalomyelitis Market by Treatment, 2020
    117. – 2027, (USD Million)
    118. Market by End Users, 2020 – 2027, (USD Million)
    119.  Asia Pacific Market by Types, 2020 – 2027, (USD Million)
    120.     Asia Pacific Encephalomyelitis Market by Treatment, 2020 –
    121. , (USD Million)
    122. Market by End Users, 2020 – 2027, (USD Million)
    123.  Middle East & Africa Market by Types, 2020 – 2027, (USD Million)
    124. Treatment, 2020 – 2027, (USD Million)
    125. East & Africa Encephalomyelitis Market by End Users, 2020 – 2027, (USD
    126. Million)
    127. Process
    128. Market
    129. Market
    130. type 2020
    131. by Treatment 2020
    132. Share, by End Users, 2020
    133. Market Share, by Region, 2020
    134. Market Share, by Country, 2020
    135. Market Share, by Country, 2020
    136. Market Share, by Country, 2020
    137. Africa Encephalomyelitis Market Share, by Country, 2020
    138.  Global Encephalomyelitis Market: Company Share Analysis, 2020 (%)
    139.     Bristol-Myers Squibb Company: Key Financials
    140.  Bristol-Myers Squibb Company: Segmental Revenue
    141.  Bristol-Myers Squibb Company: Geographical Revenue
    142.  Sanofi: Key Financials
    143. Revenue
    144.     GlaxoSmithKline Plc.: Key Financials
    145.  GlaxoSmithKline Plc.: Segmental Revenue
    146. Plc.: Geographical Revenue
    147.  Amgen, Inc: Geographical Revenue
    148. Key Financials
    149.     Bayer AG: Geographical Revenue
    150. AG : Key Financials
    151.  F. Hoffmann-La Roche Ltd: Key Financials
    152. Hoffmann-La Roche Ltd: Segmental Revenue
    153. Roche Ltd: Geographical Revenue'

    Egg Allergy Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Egg Allergy Market by Share, Size, Growth and Overview – 2030 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials